
A recent study conducted in Indonesia assessed the safety of messenger RNA and inactivated COVID-19 vaccines for pregnant women. Among 31,977 pregnant women, the majority received Sinovac's vaccine (84%), with 78.7% reporting no adverse effects after immunization. The study suggests minimal adverse effects from COVID-19 vaccination during pregnancy, providing valuable information for informed decisions by pregnant women and healthcare providers. These findings support further recommendations for COVID-19 vaccination during pregnancy.
Like
Save
Share